Dr. Chapa’s OBGYN Clinical Pearls
HT VTE Risk by Route of Administration.
6 min•9 januari 2020
Om avsnittet
Most studies on the risks of post menopausal hormone therapy have focused on the oral route of administration. Does the transdermal route of estrogen delivery reduce the risk of VTE? In this episode, we will review the ACOG committee opinion (556) and ASRM guidelines on the use of transdermal estrogen vs oral estrogen therapy.
Dr. Chapa’s OBGYN Clinical Pearls med Dr. Chapa’s Clinical Pearls finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.